Cargando…

Fertility preservation during cancer treatment: The Korean Society for Fertility Preservation clinical guidelines

While many fertility preservation (FP) options now exist for reproductive-aged cancer patients, access to these services continues to be limited. A comprehensive FP program should be organized to serve oncofertility patients effectively. Also, much effort is needed from various individuals—patients,...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Jayeon, Kim, Seul Ki, Hwang, Kyung Joo, Kim, Seok Hyun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society for Reproductive Medicine 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5783912/
https://www.ncbi.nlm.nih.gov/pubmed/29376012
http://dx.doi.org/10.5653/cerm.2017.44.4.171
_version_ 1783295352623857664
author Kim, Jayeon
Kim, Seul Ki
Hwang, Kyung Joo
Kim, Seok Hyun
author_facet Kim, Jayeon
Kim, Seul Ki
Hwang, Kyung Joo
Kim, Seok Hyun
author_sort Kim, Jayeon
collection PubMed
description While many fertility preservation (FP) options now exist for reproductive-aged cancer patients, access to these services continues to be limited. A comprehensive FP program should be organized to serve oncofertility patients effectively. Also, much effort is needed from various individuals—patients, specialists from various fields, and consultants—to facilitate FP in a timely manner. Various challenges still exist in improving access to FP programs. To improve access to FP treatment, it is important to educate oncologists and patients via electronic tools and to actively navigate patients through the system. Reproductive endocrinology practices that receive oncofertility referrals must be equipped to provide a full range of options on short notice. A multidisciplinary team approach is required, involving physicians, nurses, mental health professionals, office staff, and laboratory personnel. The bottom line of FP patient care is to understand the true nature of each patient's specific situation and to develop a patient flow system that will help build a successful FP program. Expanding the patient flow system to all comprehensive cancer centers will ensure that all patients are provided with adequate information regarding their fertility, regardless of geography.
format Online
Article
Text
id pubmed-5783912
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher The Korean Society for Reproductive Medicine
record_format MEDLINE/PubMed
spelling pubmed-57839122018-01-26 Fertility preservation during cancer treatment: The Korean Society for Fertility Preservation clinical guidelines Kim, Jayeon Kim, Seul Ki Hwang, Kyung Joo Kim, Seok Hyun Clin Exp Reprod Med Review While many fertility preservation (FP) options now exist for reproductive-aged cancer patients, access to these services continues to be limited. A comprehensive FP program should be organized to serve oncofertility patients effectively. Also, much effort is needed from various individuals—patients, specialists from various fields, and consultants—to facilitate FP in a timely manner. Various challenges still exist in improving access to FP programs. To improve access to FP treatment, it is important to educate oncologists and patients via electronic tools and to actively navigate patients through the system. Reproductive endocrinology practices that receive oncofertility referrals must be equipped to provide a full range of options on short notice. A multidisciplinary team approach is required, involving physicians, nurses, mental health professionals, office staff, and laboratory personnel. The bottom line of FP patient care is to understand the true nature of each patient's specific situation and to develop a patient flow system that will help build a successful FP program. Expanding the patient flow system to all comprehensive cancer centers will ensure that all patients are provided with adequate information regarding their fertility, regardless of geography. The Korean Society for Reproductive Medicine 2017-12 2017-12-31 /pmc/articles/PMC5783912/ /pubmed/29376012 http://dx.doi.org/10.5653/cerm.2017.44.4.171 Text en Copyright © 2017. The Korean Society for Reproductive Medicine http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review
Kim, Jayeon
Kim, Seul Ki
Hwang, Kyung Joo
Kim, Seok Hyun
Fertility preservation during cancer treatment: The Korean Society for Fertility Preservation clinical guidelines
title Fertility preservation during cancer treatment: The Korean Society for Fertility Preservation clinical guidelines
title_full Fertility preservation during cancer treatment: The Korean Society for Fertility Preservation clinical guidelines
title_fullStr Fertility preservation during cancer treatment: The Korean Society for Fertility Preservation clinical guidelines
title_full_unstemmed Fertility preservation during cancer treatment: The Korean Society for Fertility Preservation clinical guidelines
title_short Fertility preservation during cancer treatment: The Korean Society for Fertility Preservation clinical guidelines
title_sort fertility preservation during cancer treatment: the korean society for fertility preservation clinical guidelines
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5783912/
https://www.ncbi.nlm.nih.gov/pubmed/29376012
http://dx.doi.org/10.5653/cerm.2017.44.4.171
work_keys_str_mv AT kimjayeon fertilitypreservationduringcancertreatmentthekoreansocietyforfertilitypreservationclinicalguidelines
AT kimseulki fertilitypreservationduringcancertreatmentthekoreansocietyforfertilitypreservationclinicalguidelines
AT hwangkyungjoo fertilitypreservationduringcancertreatmentthekoreansocietyforfertilitypreservationclinicalguidelines
AT kimseokhyun fertilitypreservationduringcancertreatmentthekoreansocietyforfertilitypreservationclinicalguidelines